Gene variant predicts cognitive decline after stroke

FHS
July 25, 2024
5:11 am

New research led by UCLA Health has found that specific genes may be related to the trajectory of recovery for stroke survivors, providing doctors insights useful for developing targeted therapies.

Elon Musk bungles his criticism of U.S. drug regulators

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. While barnstorming across

October 24, 2024

Fertility benefits company Progyny shares how it handles startup valuations when looking for deals

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) When Progyny went public in 2019, it

October 31, 2023

Q3 biotech roundup: The 2024 turnaround sputters into a critical Q4 finale

Some, though certainly not all, chief indicators of biotech business activity are pointed shakily north as we head into a critical Q4. But biotech shows

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.